Green Synthesis of Alzheimer′s Disease Probes Aftobetin and Analogues Enabled by Flow Technology and Heterogeneous Photocatalysis
ChemSusChem · 2025
DOI: 10.1002/cssc.202401214 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemSusChem, 2025. Verfasst von Yongjiu Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Science and Technology, College of Chemistry, Fuzhou University, Fuzhou, 350108, China. Hauptthemen laut MEDLINE: Green Chemistry Technology, Alzheimer Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Qingyuan Innovation Laboratory, Innovative Research Group Project of the National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Aftobetin is a non‐invasive diagnosis of Alzheimer′s disease, that can bind with aggregated β‐amyloid peptide in eye′s lenses, used for early diagnosis of Alzheimer′s disease in a rapid and painless mode. The reported synthesis of this probe fell short in the aspects of greenness and economy due to the involvement of toxic Chromium(IV) oxidant, noble palladium catalyst, elevated reaction temperature, the long reaction time as well as the cumbersome workup. Herein, a holistic optimization of the synthetic process was achieved via the employment of flow technology and heterogenous photocatalysis. Firstly, the integration of heterogenous carbon nitrides photocatalysis and circulation flow technology furnished the air oxidation of alcohol and nickel catalyzed C−N coupling at 20 g scale, thus avoiding the use of toxic Chromium and precious palladium species respectively. Flow‐intensified esterification between acyl chloride and alcohol, just taking 30 seconds replaced the Steglich esterification of 6 hours, also avoiding the generation of difficult‐to‐remove dicyclohexylurea. Finally, C−N coupling, esterification and Knoevenagel condensation were telescoped together, thus simplifying the reaction workup. This fully‐flow protocol led to the on‐demand synthesis of eight probes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Pharmaceutical Science and Technology, College of Chemistry, Fuzhou University, Fuzhou, 350108, China.
- Qingyuan Innovation Laboratory, Quanzhou, 362801, China.
- Key Laboratory of Molecule Synthesis and Function Discovery (Fujian Province University), Fuzhou University, Fuzhou, 350108, China.
- Guangdong Provincial Key Laboratory of Chemical Measurement and Emergency Test Technology (China), Institute of Analysis, Guangdong Academy of Sciences (China National Analytical Center, Guangzhou), Guangzhou, China.
- Department of Chemistry, Institute of Biomedical Science, Fudan University, Shanghai, 200438, China.
ORCID-Profile: Chenguang Liu, Fener Chen
Förderung
- National Natural Science Foundation of China
- Qingyuan Innovation Laboratory
- Innovative Research Group Project of the National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Li, Y., Liu, X., Liu, Q., Wang, Y., Liu, C., & Chen, F. (2025). Green Synthesis of Alzheimer′s Disease Probes Aftobetin and Analogues Enabled by Flow Technology and Heterogeneous Photocatalysis. ChemSusChem. https://doi.org/10.1002/cssc.202401214
Vancouver
Li Y, Liu X, Liu Q, Wang Y, Liu C, Chen F. Green Synthesis of Alzheimer′s Disease Probes Aftobetin and Analogues Enabled by Flow Technology and Heterogeneous Photocatalysis. ChemSusChem. 2025. doi:10.1002/cssc.202401214
BibTeX
@article{Li2025,
author = {Li, Yongjiu and Liu, Xin and Liu, Qiong and Wang, Yuchen and Liu, Chenguang and Chen, Fener},
title = {Green Synthesis of Alzheimer′s Disease Probes Aftobetin and Analogues Enabled by Flow Technology and Heterogeneous Photocatalysis},
journal = {ChemSusChem},
year = {2025},
doi = {10.1002/cssc.202401214}
}
EUVIMED